.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Colorcon
Queensland Health
Argus Health
Julphar
Cantor Fitzgerald
Cerilliant
Cipla
Accenture
Teva

Generated: June 22, 2017

DrugPatentWatch Database Preview

Mezlocillin sodium monohydrate - Generic Drug Details

« Back to Dashboard

What are the generic sources for mezlocillin sodium monohydrate and what is the scope of mezlocillin sodium monohydrate freedom to operate?

Mezlocillin sodium monohydrate
is the generic ingredient in one branded drug marketed by Bayer Pharms and is included in four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Summary for Generic Name: mezlocillin sodium monohydrate

Tradenames:1
Patents:1
Applicants:1
NDAs:4
Bulk Api Vendors: see list39
Clinical Trials: see list2,419
Patent Applications: see list4,958
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:mezlocillin sodium monohydrate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Pharms
MEZLIN
mezlocillin sodium monohydrate
INJECTABLE;INJECTION062372-005Jan 13, 1983DISCNNoNo► Subscribe► Subscribe
Bayer Pharms
MEZLIN
mezlocillin sodium monohydrate
INJECTABLE;INJECTION062697-002Jan 22, 1987DISCNNoNo► Subscribe► Subscribe
Bayer Pharms
MEZLIN
mezlocillin sodium monohydrate
INJECTABLE;INJECTION050549-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Bayer Pharms
MEZLIN
mezlocillin sodium monohydrate
INJECTABLE;INJECTION062333-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Bayer Pharms
MEZLIN
mezlocillin sodium monohydrate
INJECTABLE;INJECTION062333-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Harvard Business School
US Department of Justice
Moodys
Dow
Cantor Fitzgerald
Daiichi Sankyo
Queensland Health
Chubb
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot